HMGB1 and non-small cell lung carcinoma: Furthermore, HMGB1 overexpression in NSCLC correlates with increased P-gp expression, enhanced proliferation, and cisplatin resistance, further linking cytoplasmic HMGB1 to multidrug-resistance phenotypes [208].